SENORES PHARMACEUTICALS L Capital Reinvestment Ratio

Latest as of September 2025: 3.99x

SENORES PHARMACEUTICALS L capital reinvestment ratio. SENORES PHARMACEUTICALS L (SENORES) has a Capital Reinvestment Ratio of 3.99x as of September 2025, meaning it reinvests 4% of its operating cash flow (Rs242.20 Million) in capital expenditures (Rs966.90 Million). Check SENORES PHARMACEUTICALS L total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

3.99x

Capex / Operating Cash Flow

Operating Cash Flow

Rs242.20 Million

INR

Capital Expenditures

Rs966.90 Million

INR

Data as of

Sep 2025

Most recent filing

Capital Reinvestment Ratio of SENORES PHARMACEUTICALS L (2026–2026)

Capital reinvestment ratio of SENORES PHARMACEUTICALS L from 2026 to 2026. This chart tracks SENORES PHARMACEUTICALS L's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of SENORES PHARMACEUTICALS L to track the company's year-over-year net asset growth rate.

SENORES PHARMACEUTICALS L Capital Reinvestment Ratio by Year (2026–2026)

SENORES PHARMACEUTICALS L capital reinvestment ratio by year from 2026 to 2026. For the full cash flow conversion analysis, see SENORES PHARMACEUTICALS L (SENORES) cash flow conversion.

Year	Reinvestment Ratio	Operating CF (INR)	Capital Expenditures	YoY Change
2026	4.27x	Rs620.50 Million	Rs2.65 Billion	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow